| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Feb 14, 2025 | ZEVRA THERAPEUTICS, INC. | CFO | Sell | 20.0 | -11,000 | -17.64% | ✓ | $86.5K |
| Jul 17, 2024 | Jul 17, 2024 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 91.3 | +2,000 | 12.14% | ✗ | $13.5K |
| Sep 6, 2023 | Sep 6, 2023 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 85.0 | +1,000 | 6.99% | ✗ | $5K |
| May 18, 2023 | May 18, 2023 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 91.3 | +2,740 | 24.90% | ✗ | $13.6K |
| Mar 10, 2023 | Mar 13, 2023 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +1,725 | 18.59% | ✗ | $7.2K |
| Jan 13, 2023 | Jan 13, 2023 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 85.0 | +635 | 7.35% | ✗ | $3.7K |
| Sep 30, 2022 | Oct 3, 2022 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +1,000 | 14.07% | ✗ | $6K |
| May 18, 2022 | May 18, 2022 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +1,200 | 22.90% | ✗ | $6K |
| Nov 18, 2021 | Nov 18, 2021 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +510 | 10.78% | ✗ | $4.2K |
| Sep 29, 2021 | Sep 29, 2021 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 82.5 | +215 | 4.76% | ✗ | $2K |
| Sep 20, 2021 | Sep 20, 2021 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +935 | 26.12% | ✗ | $8K |
| Sep 1, 2021 | Sep 1, 2021 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 85.0 | +230 | 6.87% | ✗ | $2.1K |
| Jun 23, 2021 | Jun 24, 2021 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 77.5 | +75 | 2.29% | ✗ | $1.1K |
| May 27, 2021 | May 27, 2021 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 82.5 | +150 | 4.80% | ✗ | $1.5K |
| Aug 26, 2020 | Aug 26, 2020 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 77.5 | +1,000 | 2.04% | ✗ | $839 |
| Aug 18, 2020 | Aug 18, 2020 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 82.5 | +2,000 | 4.26% | ✗ | $1.4K |
| Jun 11, 2020 | Jun 11, 2020 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 82.5 | +1,500 | 3.30% | ✗ | $288.5 |
| May 26, 2020 | May 26, 2020 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +11,500 | 33.82% | ✗ | $2.1K |
| Mar 25, 2020 | Mar 25, 2020 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 82.5 | +1,000 | 3.03% | ✗ | $218.2 |
| Mar 11, 2020 | Mar 12, 2020 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +8,000 | 32.00% | ✗ | $2K |
| Dec 27, 2019 | Dec 30, 2019 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +12,250 | 96.08% | ✗ | $5.1K |
| Sep 25, 2019 | Sep 25, 2019 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +3,650 | 40.11% | ✗ | $2.7K |
| Sep 16, 2019 | Sep 16, 2019 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +5,000 | 121.95% | ✗ | $4.4K |
| Sep 11, 2019 | Sep 11, 2019 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +500 | 13.89% | ✗ | $472.6 |
| Sep 6, 2019 | Sep 6, 2019 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +850 | 30.91% | ✗ | $652.3 |
| Oct 11, 2018 | Oct 11, 2018 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +650 | 30.95% | ✗ | $1.7K |
| May 31, 2018 | Jun 1, 2018 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +525 | 33.33% | ✗ | $3.2K |
| Sep 25, 2017 | Sep 25, 2017 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +300 | 23.53% | ✗ | $1.1K |
| Jun 19, 2017 | Jun 21, 2017 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +275 | 27.50% | ✗ | $907.5 |
| Mar 24, 2017 | Mar 27, 2017 | ZEVRA THERAPEUTICS, INC. | CFO | Buy | 90.0 | +1,000 | 100.00% | ✗ | $4.2K |
| Aug 31, 2011 | Sep 1, 2011 | LGL GROUP INC | Chief Accounting Officer | Buy | 77.5 | +51 | 1.43% | ✗ | $392.7 |
| May 17, 2011 | May 19, 2011 | LGL GROUP INC | Chief Accounting Officer | Buy | 77.5 | +50 | 1.43% | ✗ | $557.5 |
| Apr 7, 2010 | Apr 8, 2010 | LGL GROUP INC | Chief Accounting Officer | Buy | 90.0 | +200 | 100.00% | ✗ | $1.2K |